Acadia Healthcare (NASDAQ:ACHC) Given a $82.00 Price Target at UBS Group

UBS Group set a $82.00 price target on Acadia Healthcare (NASDAQ:ACHC – Get Rating) in a research report released on Monday, Stock Target Advisor reports.

Several other research analysts have also recently commented on ACHC. SVB Leerink raised their target price on shares of Acadia Healthcare from $80.00 to $90.00 and gave the stock an outperform rating in a report on Friday, April 8th. BMO Capital Markets upped their target price on shares of Acadia Healthcare from $67.00 to $82.00 in a report on Friday, May 6th. Loop Capital started coverage on shares of Acadia Healthcare in a research report on Thursday, June 16th. They issued a hold rating and a $72.00 target price for the company. Credit Suisse Group lifted their price target on shares of Acadia Healthcare from $74.00 to $78.00 and gave the company an outperform rating in a report on Wednesday, March 2nd. Finally, Mizuho upped their price target on shares of Acadia Healthcare from $64.00 to $69.00 in a report on Wednesday, May 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of Hold and an average price target of $75.57.

Shares of Acadia Healthcare stock opened at $68.50 on Monday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.29 and a current ratio of 1.29. Acadia Healthcare has a 1 year low of $50.07 and a 1 year high of $76.69. The company’s fifty day moving average is $69.56 and its two-hundred day moving average is $63.07. The company has a market capitalization of $6.20 billion, a P/E ratio of 25.75, a PEG ratio of 1.74 and a beta of 1.28.

Acadia Healthcare (NASDAQ:ACHC – Get Rating) last released its quarterly earnings results on Tuesday, May 3rd. The company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.63 by $0.04. Acadia Healthcare had a net margin of 10.16% and a return on equity of 10.16%. The business had revenue of $616.65 million during the quarter, compared to analyst estimates of $606.49 million. During the same quarter in the prior year, the firm earned $0.47 earnings per share. The company’s quarterly revenue was up 11.9% on a year-over-year basis. As a group, equities analysts expect that Acadia Healthcare will post 3.09 earnings per share for the current year.

A number of large investors have recently modified their holdings of the business. Walleye Capital LLC purchased a new stake in shares of Acadia Healthcare during the first quarter valued at about $216,000. Sawtooth Solutions LLC purchased a new position in shares of Acadia Healthcare in the 1st quarter valued at about $256,000. BNP Paribas Arbitrage SA lifted its stake in Acadia Healthcare by 117.3% during the first quarter. BNP Paribas Arbitrage SA now owns 31,412 shares of the company’s stock worth $2,058,000 after purchasing an additional 16,954 shares during the last quarter. Keeley Teton Advisors LLC increased its holdings in shares of Acadia Healthcare by 35.9% in the first quarter. Keeley Teton Advisors LLC now owns 31,689 shares of the company’s stock valued at $2,077,000 after purchasing an additional 8,370 shares during the period. Finally, Mirabella Financial Services LLP grew its holdings in Acadia Healthcare by 132.3% in the first quarter. Mirabella Financial Services LLP now owns 42,571 shares of the company’s stock valued at $2,790,000 after purchasing an additional 24,243 shares during the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

About Acadia Healthcare (Get Rating)

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico.

Read More